text stringlengths 33 172 |
|---|
What are the characteristics of the starting point of Alzheimer's disease in the brain? |
If there is single-cell RNA sequencing data available for the starting point of Alzheimer's disease in the brain, please provide it. |
Compare the single-cell RNA sequencing data from the brains of human Alzheimer's patients and mouse models of Alzheimer's disease to identify similarities and differences. |
Identify candidate disease-related genes by comparing single-cell RNA sequencing data from the brains of human Alzheimer's patients and mouse models of Alzheimer's disease. |
Beyond the genes already known to be strongly associated with Alzheimer's disease, suggest other potential candidate genes that may be linked to the disease. |
Beyond the currently known cellular pathways strongly associated with Alzheimer's disease, suggest potential new candidate pathways that may be relevant. |
Identify metabolic products known to have strong associations with Alzheimer's disease. |
Provide information on the metabolic pathways that are known to be disrupted in the brains of Alzheimer's patients. |
Find genes that show common regulatory changes in both aging brains and Alzheimer's disease brains. |
Analyze Alzheimer's disease from an evolutionary perspective. |
Explain the relationship between Alzheimer's disease and myokines. |
Identify potential myokine candidates that may be associated with Alzheimer's disease. |
Discuss the relationship between nutrients and Alzheimer's disease. |
List all genes discovered through Alzheimer's disease model studies. |
Provide examples of genes discovered in Alzheimer's disease model studies that have also been validated for relevance in actual patient brains. |
Identify Alzheimer's disease-associated factors that are specific to glial cells. |
Explain the association between microglia and Alzheimer's disease. |
Describe the association between astrocytes and Alzheimer's disease. |
Provide information on changes in autophagy observed in the brains of Alzheimer's disease patients. |
Discuss the relationship between Alzheimer's disease and iron (Fe). |
What types of hormones are associated with Alzheimer's disease? |
Why are women more likely to develop Alzheimer's disease compared to men? |
What signaling pathways are associated with Alzheimer's disease? |
What is the relationship between Alzheimer's disease and proteins? |
Are there specific amino acids associated with Alzheimer's disease? |
Are there specific polysaccharides associated with Alzheimer's disease? |
Have region-specific mutations been identified in Alzheimer's disease? |
What are the specific characteristics of Alzheimer's disease in the Korean population? |
How do lipid components in the brains of Alzheimer's disease patients differ from those in normal individuals? |
How do carbohydrate components in the brains of Alzheimer's disease patients differ from those in normal individuals? |
How do protein components in the brains of Alzheimer's disease patients differ from those in normal individuals? |
Why does the prevalence of Alzheimer's disease increase with age? |
What are the current blood diagnostic methods for Alzheimer's disease? |
How do lipid components in the blood of Alzheimer's disease patients differ from those in normal individuals? |
How do nucleic acid components in the blood of Alzheimer's disease patients differ from those in normal individuals? |
How do protein components in the blood of Alzheimer's disease patients differ from those in normal individuals? |
What are the changes in proteins in the blood of Alzheimer's disease patients compared to normal individuals? |
What biomarkers appear at different stages of Alzheimer's disease? |
What modifications occur in tau proteins in the blood of Alzheimer's disease patients? |
What is known about lipid droplet accumulation in glial cells of Alzheimer's disease patients? |
What are all the familial Alzheimer's disease-associated genes? |
What are the latest diagnostic methods for Alzheimer's disease? |
What are the effects of a ketogenic diet on Alzheimer's disease? |
What is the relationship between Alzheimer's disease and the nucleolus? |
Which nucleolar-localized proteins are known to be associated with Alzheimer's disease? |
What is the role of ferroptosis in Alzheimer's disease? |
What are the epigenetic differences between the brains of Alzheimer's disease patients and those of normal individuals? |
What is the relationship between CCDC86 and Alzheimer's disease? |
What senescence-associated secretory phenotypes (SASP) increase in the brains of Alzheimer's disease patients compared to normal individuals? |
What senescence-associated secretory phenotypes (SASP) decrease in the brains of Alzheimer's disease patients compared to normal individuals? |
What is the relationship between the ephrin-ephrin receptor signaling pathway and Alzheimer's disease? |
What changes in ephrin-ephrin receptor signaling have been observed in the brains of Alzheimer's disease patients? |
Can inhibiting apoptosis help alleviate Alzheimer's disease? |
What are all the proteins known to inhibit the aggregation of amyloid-beta? |
What signaling pathways are known to inhibit the aggregation of amyloid-beta? |
What are the mechanisms of action of splicing-related factors in the pathogenesis of Alzheimer's disease? |
What is the list of genes known to exhibit splicing alterations during the pathogenesis of Alzheimer's disease? |
What changes occur in microglia during the progression of Alzheimer's disease? |
What substances are known to inhibit tau protein aggregation? |
Could inhibiting tau protein aggregation serve as a therapeutic approach for Alzheimer's disease? |
What is the relationship between the ubiquitin-proteasome system and Alzheimer's disease? |
How might the principles of phase separation be related to Alzheimer's disease? |
Are there research findings on lipid droplet accumulation in the brains of Alzheimer's disease patients? |
Does activating autophagy provide neuroprotection in the brains of Alzheimer's disease models? |
Does intracellular Zn accumulation influence Alzheimer's disease? |
What is the relationship between intracellular Zn transport-related factors and Alzheimer's disease? |
In a Drosophila Alzheimer's disease model, are the morphology or number of glial cells in the brain different from the control group? |
Are there research findings on lipid changes in the brains of Drosophila neurodegenerative disease models? |
Why is lifespan reduced in Drosophila neurodegenerative disease models compared to the control group? |
What types of studies could be conducted using a Drosophila Alzheimer's disease model to yield novel findings? |
Why have Alzheimer's disease-associated genes not been evolutionarily eliminated? |
From the known Alzheimer's disease-associated genes, identify only the transcription factors. |
Which is more critical in Alzheimer's disease: autophagy in neurons or autophagy in glial cells? |
List all small molecules known to inhibit the aggregation of amyloid-beta. |
Beyond inhibiting amyloid-beta aggregation, what other therapeutic approaches are effective for Alzheimer's disease? |
Propose three molecular mechanisms through which fatty acid binding proteins might be implicated in Alzheimer's disease pathology. |
How do loss-of-function mutations in splicing factors contribute to amyloid-beta aggregation? |
Is amyloid-beta aggregation truly the direct cause of Alzheimer's disease? |
Why are severe amyloid-beta aggregations not observed in the brains of some Alzheimer's patients? |
Why do some individuals with severe amyloid-beta aggregation in the brain not develop Alzheimer's disease? Propose potential mechanisms based on existing research findings. |
Is the difference between amyloid beta 40 and amyloid beta 42 critical? |
What newly discovered forms of amyloid beta have been identified? |
Summarize the enzymes involved in amyloid beta cleavage. |
What is the relationship between collagen remodeling and Alzheimer's disease? |
What types of collagen are associated with Alzheimer's disease? |
Explain the specific relationship between the microbiome and Alzheimer's disease. |
Which secretory proteins from the microbiome are associated with Alzheimer's disease? |
Which metabolites from the microbiome are associated with Alzheimer's disease? |
What molecular mechanisms link the linear ubiquitination system to Alzheimer's disease? |
What changes in global translation have been observed in the brains of Alzheimer's disease patients? |
What is the relationship between translation-related factors and the pathogenesis of Alzheimer's disease? |
Provide a list of longevity-associated genes that are linked to Alzheimer's disease. |
List innovative treatments being developed for Alzheimer's disease and their mechanisms of action. |
What is the relationship between Alzheimer's disease and other diseases? |
Why is the lifespan of Alzheimer's disease patients reduced? |
Provide a list of natural products known to have beneficial effects on dementia. |
List herbal medicines from traditional Chinese medicine that are known to be effective for dementia. |
List herbal medicines from traditional Indian medicine (Ayurveda) that are known to be effective for dementia. |
What is the relationship between the Wnt signaling pathway and Alzheimer's disease? |
What is the mechanism behind the loss of smell (anosmia) in Alzheimer's disease patients? |
End of preview. Expand in Data Studio
Searching for the Best Practices of Query Reformulation in Bio-Insight Generation
This repository provides the experimental queries and documents used in the research paper "Searching for the Best Practices of Query Reformulation in Bio-Insight Generation". It is designed to support the reproducibility of the retrieval performance reported in the study.
1. Dataset Summary
The dataset includes a curated collection of biological and medical queries designed for Bio-Insight generation. The study evaluates various query reformulation techniques to identify the best practices for enhancing retrieval accuracy in the biomedical domain.
2. File Structure
data/:- queries_eng.txt: User-centered queries reflecting real-world information-seeking behaviors and experimental contexts.
documents.tsv: A specialized corpus consisting of PubMed article abstracts published between 2015 and 2024. The corpus is focused on Alzheimer’s disease, dementia, and neurodegenerative diseases. To optimize retrieval recall and minimize processing costs, the collection utilizes abstracts rather than full-text articles, ensuring relevance by focusing on recent, high-impact research.
index/:- Pre-computed DPR indices built from the aforementioned PubMed abstract corpus for efficient Bio-Insight generation.
- Note: Model checkpoints are not included in this repository.
3. Implementation & Reproducibility
The source code for replicating the query reformulation experiments and the retrieval pipeline can be found in our GitHub repository: [https://github.com/yeomsee/best_practices_bio_rag]
4. Citation
If you find this dataset or the associated research useful, please cite our paper:
Searching for the Best Practices of Query Reformulation in Bio-Insight Generation.
- Downloads last month
- 6